Hepatocellular carcinoma is usually detected late and therapeutic options are unsatisfactory.
Despite marked progress in patient care, HCC remains among the deadliest cancers world …

Ovarian cancer is a common gynecological malignancy, and its treatment remains
challenging. Although ovarian cancer may respond to immunotherapy because of …

Simple Summary Cancer is a leading cause of death worldwide and continuous efforts are
exerted to develop novel biomarkers and therapeutic agents that could help in early …

Replication Factor C Subunit 4 (RFC4), an oncogene implicated in many human cancers,
has yet to be extensively studied in many cancer types to determine its expression patterns …

Background Cervical cancer (CC) is the most common gynecological tumor disease in
women, which occurs at the junction of cervical squamous columnar epithelium. We …

Beauvericin (BEA) is an emerging mycotoxin produced by some species of Fusarium genera
that widely contaminates food and feed. Gentiana lutea is a protected medicinal plant known …

In the case of hepatocellular carcinoma, there is a need to find novel immune biomarkers to
predict cancer prognosis, which will help prolong patient survival. On the basis of these …

Cyclin dependent kinase inhibitor 2A (CDKN2A) is a well-known tumor suppressor gene as
it functions as a cell cycle regulator. While several reports correlate the malfunction of …

Objective Exploring the different molecular and clinicopathological features of nodal cancer
based on single cell sequencing can reveal the intertumoral heterogeneity in cancer, and …

Background: Invasive ductal carcinoma (IDC) is the most common type of breast cancer (BC)
worldwide. Nowadays, due to its heterogeneity and high capacity for metastasis, it is …